U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07349797) titled 'MediBeacon(R) Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure' on Jan. 15.
Brief Summary: The goal of this clinical trial is to evaluate the accuracy and feasibility of transdermal glomerular filtration rate (tGFR) assessment using relmapirazin (Lumitrace) and the MediBeacon tGFR system compared to plasma clearance measurement of GFR in adults with heart failure.
The main question it aims to answer is the comparison of the transdermal-derived GFR for each participant using the MediBeacon tGFR to their nGFRBSA measurement.
Participants will participate in a Screening visit that will take pl...